CAS: 21416-67-1 - Razoxane
Formel:C11H16N4O4
InChl:InChI=1S/C11H16N4O4/c1-7(15-5-10(18)13-11(19)6-15)2-14-3-8(16)12-9(17)4-14/h7H,2-6H2,1H3,(H,12,16,17)(H,13,18,19)
InChI Key:InChIKey=BMKDZUISNHGIBY-UHFFFAOYSA-N
SMILES:O=C1NC(=O)CN(C1)CC(N2CC(=O)NC(=O)C2)C
- Synonyme:
- (±)-1,2-Bis(3,5-dioxopiperazin-1-yl)propane
- (±)-1,2-Bis(3,5-dioxopiperazinyl)propane
- 1,2-Bis(3,5-dioxo-1-piperazinyl)propane
- 2,6-Piperazinedione, 4,4'-(1-Methyl-1,2-Ethanediyl)Bis-
- 2,6-Piperazinedione, 4,4′-propylenedi-
- 21416-67-1
- 4,4'-Propane-1,2-diyldipiperazine-2,6-dione
- 4,4'-Propane-1,3-Diyldipiperazine-2,6-Dione
- 4,4'-Propylenebis(Piperazine-2,6-Dione)
- 4,4′-(1-Methyl-1,2-ethanediyl)bis[2,6-piperazinedione]
- Mehr Synonyme anzeigen
- 4,4′-Propylenebis(2,6-piperazinedione)
- 4,4′-Propylenedi(2,6-piperazinedione)
- Ici 59118
- Icrf 159
- NSC 129943
- Razoxin
- Tepirone
- Troxozone
Marke | Produktdaten | Reinheit | Preisklasse | Voraussichtliche Lieferung |
---|---|---|---|---|
4,4'-propylenebis(piperazine-2,6-dione) REF: IN-DA007QKYCAS: 21416-67-1 | 95% | 170,00 €~583,00 € | Di 07 Jan 25 | |
4,4'-(Propane-1,2-diyl)bis(piperazine-2,6-dione) REF: 10-F079510CAS: 21416-67-1 | 95.0% | 184,00 €~600,00 € | Mi 08 Jan 25 | |
Razoxane REF: TM-T26046CAS: 21416-67-1 | 99.42% | 96,00 €~1.012,00 € | Di 14 Jan 25 | |
Razoxane REF: TR-R128060CAS: 21416-67-1 | - - - | - - - | Ausgelaufenes produkt | |
4,4'-propylenebis(piperazine-2,6-dione) REF: 3D-FP156423CAS: 21416-67-1 | Min. 95% | - - - | Ausgelaufenes produkt |
4,4'-propylenebis(piperazine-2,6-dione)
Ref: IN-DA007QKY
1g | 583,00 € | ||
100mg | 170,00 € | ||
250mg | 179,00 € |
4,4'-(Propane-1,2-diyl)bis(piperazine-2,6-dione)
Ref: 10-F079510
1g | 600,00 € | ||
100mg | 184,00 € | ||
250mg | 259,00 € |
Razoxane
Ref: TM-T26046
1mg | 96,00 € | ||
5mg | 230,00 € | ||
10mg | 337,00 € | ||
25mg | 575,00 € | ||
50mg | 759,00 € | ||
100mg | 1.012,00 € | ||
1mL*10mM (DMSO) | 210,00 € |
Razoxane
Ref: TR-R128060
1g | Ausgelaufen | Anforderung von Informationen | |
100mg | Ausgelaufen | Anforderung von Informationen | |
250mg | Ausgelaufen | Anforderung von Informationen |
4,4'-propylenebis(piperazine-2,6-dione)
Ref: 3D-FP156423
10mg | Ausgelaufen | Anforderung von Informationen | |
25mg | Ausgelaufen | Anforderung von Informationen | |
50mg | Ausgelaufen | Anforderung von Informationen |